Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of β-catenin, and enhanced tumor cell invasion

Cancer Cell

Volumn 4, Issue 6, 2003, Pages 499-515

  Lu, Zhimin ^a,b   Ghosh, Sourav ^a   Wang, Zhiyong ^a   Hunter, Tony ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CAVEOLIN 1; COMPLEMENTARY RNA; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; LYMPHOID ENHANCER FACTOR 1; T CELL FACTOR PROTEIN; UVOMORULIN;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CANCER INVASION; CELL ADHESION; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; EPITHELIUM CELL; GENE SNAIL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; MESENCHYME CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; REPRESSOR GENE; TRANSCRIPTION REGULATION; TUMOR CELL; UPREGULATION;

ANIMALIA; GASTROPODA;

EID: 0345736990     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00304-0     Document Type: Article

References (124)

1. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16:1997;3797-3804.
2. Akhtar N., Hotchin N.A. RAC1 regulates adherens junctions through endocytosis of E-cadherin. Mol. Biol. Cell. 12:2001;847-862.
3. Al Moustafa A.E., Yansouni C., Alaoui-Jamali M.A., O'Connor-McCourt M. Up-regulation of E-cadherin by an anti-epidermal growth factor receptor monoclonal antibody in lung cancer cell lines. Clin. Cancer Res. 5:1999;681-686.
4. Al Moustafa A.E., Yen L., Benlimame N., Alaoui-Jamali M.A. Regulation of E-cadherin/catenin complex patterns by epidermal growth factor receptor modulation in human lung cancer cells. Lung Cancer. 37:2002;49-56.
5. Anderson R.G. The caveolae membrane system. Annu. Rev. Biochem. 67:1998;199-225.
6. Bagnoli M., Tomassetti A., Figini M., Flati S., Dolo V., Canevari S., Miotti S. Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression. Oncogene. 19:2000;4754-4763.
7. Batlle E., Sancho E., Franci C., Dominguez D., Monfar M., Baulida J., Garcia De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2:2000;84-89.
8. Behrens J., Jerchow B.A., Wurtele M., Grimm J., Asbrand C., Wirtz R., Kuhl M., Wedlich D., Birchmeier W. Functional interaction of an axin homolog, conductin, with beta- catenin, APC, and GSK3beta. Science. 280:1998;596-599.
9. Bender F.C., Reymond M.A., Bron C., Quest A.F. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res. 60:2000;5870-5878.
10. Benmerah A., Bayrou M., Cerf-Bensussan N., Dautry-Varsat A. Inhibition of clathrin-coated pit assembly by an Eps15 mutant. J. Cell Sci. 112:1999;1303-1311.
11. Benmerah A., Poupon V., Cerf-Bensussan N., Dautry-Varsat A. Mapping of Eps15 domains involved in its targeting to clathrin-coated pits. J. Biol. Chem. 275:2000;3288-3295.
12. Berger M.S., Greenfield C., Gullick W.J., Haley J., Downward J., Neal D.E., Harris A.L., Waterfield M.D. Evaluation of epidermal growth factor receptors in bladder tumours. Br. J. Cancer. 56:1987;533-537.
13. Berx G., Becker K.F., Hofler H., van Roy F. Mutations of the human E-cadherin (CDH1) gene. Hum. Mutat. 12:1998;226-237.
14. Birchmeier W., Hulsken J., Behrens J. Adherens junction proteins in tumour progression. Cancer Surv. 24:1995;129-140.
15. Blay J., Brown K.D. Epidermal growth factor promotes the chemotactic migration of cultured rat intestinal epithelial cells. J. Cell. Physiol. 124:1985;107-112.
16. Brabletz T., Jung A., Reu S., Porzner M., Hlubek F., Kunz-Schughart L.A., Knuechel R., Kirchner T. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc. Natl. Acad. Sci. USA. 98:2001;10356-10361.
17. Brummelkamp T.R., Bernards R., Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell. 2:2002;243-247.
18. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F., Nieto M.A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2:2000;76-83.
19. Chan E.F., Gat U., McNiff J.M., Fuchs E. A common human skin tumour is caused by activating mutations in beta-catenin. Nat. Genet. 21:1999;410-413.
20. Comijn J., Berx G., Vermassen P., Verschueren K., van Grunsven L., Bruyneel E., Mareel M., Huylebroeck D., van Roy F. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell. 7:2001;1267-1278.
21. Cox R.T., Kirkpatrick C., Peifer M. Armadillo is required for adherens junction assembly, cell polarity, and morphogenesis during Drosophila embryogenesis. J. Cell Biol. 134:1996;133-148.
22. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., Menne J., Lindschau C., Mende F., Luft F.C.et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science. 293:2001;2449-2452.
23. Efstathiou J.A., Liu D., Wheeler J.M., Kim H.C., Beck N.E., Ilyas M., Karayiannakis A.J., Mortensen N.J., Kmiot W., Playford R.J.et al. Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells. Proc. Natl. Acad. Sci. USA. 96:1999;2316-2321.
24. Eger A., Stockinger A., Schaffhauser B., Beug H., Foisner R. Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of beta-catenin and upregulation of beta-catenin/lymphoid enhancer binding factor-1 transcriptional activity. J. Cell Biol. 148:2000;173-188.
25. Engelman J.A., Zhang X.L., Razani B., Pestell R.G., Lisanti M.P. p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. Activation of Ras-MAP kinase and protein kinase a signaling cascades transcriptionally down-regulates caveolin-1 promoter activity. J. Biol. Chem. 274:1999;32333-32341.
26. Ethier S.P., Langton B.C., Dilts C.A. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha. Mol. Carcinog. 15:1996;134-143.
27. Frixen U.H., Behrens J., Sachs M., Eberle G., Voss B., Warda A., Lochner D., Birchmeier W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113:1991;173-185.
28. Fujita Y., Krause G., Scheffner M., Zechner D., Leddy H.E., Behrens J., Sommer T., Birchmeier W. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat. Cell Biol. 4:2002;222-231.
29. Galbiati F., Volonte D., Brown A.M., Weinstein D.E., Ben-Ze'ev A., Pestell R.G., Lisanti M.P. Caveolin-1 expression inhibits Wnt/beta-catenin/ Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains. J. Biol. Chem. 275:2000;23368-23377.
30. Galbiati F., Razani B., Lisanti M.P. Emerging themes in lipid rafts and caveolae. Cell. 106:2001;403-411.
31. Garcia-Cardena G., Martasek P., Masters B.S., Skidd P.M., Couet J., Li S., Lisanti M.P., Sessa W.C. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J. Biol. Chem. 272:1997;25437-25440.
32. Gat U., DasGupta R., Degenstein L., Fuchs E. De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell. 95:1998;605-614.
33. Geimer P., Bade E.G. The epidermal growth factor-induced migration of rat liver epithelial cells is associated with a transient inhibition of DNA synthesis. J. Cell Sci. 100:1991;349-355.
34. Gottardi C.J., Wong E., Gumbiner B.M. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J. Cell Biol. 153:2001;1049-1060.
35. Grande M., Franzen A., Karlsson J.O., Ericson L.E., Heldin N.E., Nilsson M. Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J. Cell Sci. 115:2002;4227-4236.
36. Guilford P., Hopkins J., Harraway J., McLeod M., McLeod N., Harawira P., Taite H., Scoular R., Miller A., Reeve A.E. E-cadherin germline mutations in familial gastric cancer. Nature. 392:1998;402-405.
37. Gullick W.J. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br. Med. Bull. 47:1991;87-98.
38. Gumbiner B.M. Regulation of cadherin adhesive activity. J. Cell Biol. 148:2000;399-404.
39. Hay E.D., Zuk A. Transformations between epithelium and mesenchyme. normal, pathological, and experimentally induced Am. J. Kidney Dis. 26:1995;678-690.
40. Hayashi K., Matsuda S., Machida K., Yamamoto T., Fukuda Y., Nimura Y., Hayakawa T., Hamaguchi M. Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res. 61:2001;2361-2364.
41. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science. 281:1998;1509-1512.
42. Hicke L. A new ticket for entry into budding vesicles-ubiquitin. Cell. 106:2001;527-530.
43. Huelsken J., Vogel R., Brinkmann V., Erdmann B., Birchmeier C., Birchmeier W. Requirement for beta-catenin in anterior-posterior axis formation in mice. J. Cell Biol. 148:2000;567-578.
44. Hulit J., Bash T., Fu M., Galbiati F., Albanese C., Sage D.R., Schlegel A., Zhurinsky J., Shtutman M., Ben-Ze'ev A.et al. The cyclin D1 gene is transcriptionally repressed by caveolin-1. J. Biol. Chem. 275:2000;21203-21209.
45. Hulsken J., Birchmeier W., Behrens J. E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J. Cell Biol. 127:1994;2061-2069.
46. Ikeda S., Kishida S., Yamamoto H., Murai H., Koyama S., Kikuchi A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J. 17:1998;1371-1384.
47. Kamei T., Matozaki T., Sakisaka T., Kodama A., Yokoyama S., Peng Y.F., Nakano K., Takaishi K., Takai Y. Coendocytosis of cadherin and c-Met coupled to disruption of cell-cell adhesion in MDCK cells - regulation by Rho, Rac and Rab small G proteins. Oncogene. 18:1999;6776-6784.
48. Kato K., Hida Y., Miyamoto M., Hashida H., Shinohara T., Itoh T., Okushiba S., Kondo S., Katoh H. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer. 94:2002;929-933.
49. Koleske A.J., Baltimore D., Lisanti M.P. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. USA. 92:1995;1381-1385.
50. Kumar R., Mendelsohn J. Growth regulation of A431 cells. Modulation of expression of transforming growth factor-alpha mRNA and 2′,5′- oligoadenylate synthetase activity. J. Biol. Chem. 265:1990;4578-4582.
51. Le T.L., Yap A.S., Stow J.L. Recycling of E-cadherin. a potential mechanism for regulating cadherin dynamics J. Cell Biol. 146:1999;219-232.
52. Lee S.W., Reimer C.L., Oh P., Campbell D.B., Schnitzer J.E. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene. 16:1998;1391-1397.
53. Lee H., Park D.S., Razani B., Russell R.G., Pestell R.G., Lisanti M.P. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer. caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia Am. J. Pathol. 161:2002;1357-1369.
54. Lemoine N.R., Hughes C.M., Gullick W.J., Brown C.L., Wynford-Thomas D. Abnormalities of the EGF receptor system in human thyroid neoplasia. Int. J. Cancer. 49:1991;558-561.
55. Li L., Yang G., Ebara S., Satoh T., Nasu Y., Timme T.L., Ren C., Wang J., Tahir S.A., Thompson T.C. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Res. 61:2001;4386-4392.
56. Libermann T.A., Nusbaum H.R., Razon N., Kris R., Lax I., Soreq H., Whittle N., Waterfield M.D., Ullrich A., Schlessinger J. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature. 313:1985;144-147.
57. Lippincott-Schwartz J., Snapp E., Kenworthy A. Studying protein dynamics in living cells. Nat. Rev. Mol. Cell Biol. 2:2001;444-456.
58. Lobie P.E., Sadir R., Graichen R., Mertani H.C., Morel G. Caveolar internalization of growth hormone. Exp. Cell Res. 246:1999;47-55.
59. Lu Z., Liu D., Hornia A., Devonish W., Pagano M., Foster D.A. Activation of protein kinase C triggers its ubiquitination and degradation. Mol. Cell. Biol. 18:1998;839-845.
60. Lu M.L., Schneider M.C., Zheng Y., Zhang X., Richie J.P. Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J. Biol. Chem. 276:2001;13442-13451. a.
61. Lu Z., Jiang G., Blume-Jensen P., Hunter T. Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol. Cell. Biol. 21:2001;4016-4031. b.
62. Ma L., Gauville C., Berthois Y., Degeorges A., Millot G., Martin P.M., Calvo F. Role of epidermal-growth-factor receptor in tumor progression in transformed human mammary epithelial cells. Int. J. Cancer. 78:1998;112-119.
63. Marsh M., McMahon H.T. The structural era of endocytosis. Science. 285:1999;215-220.
64. Miettinen P.J., Ebner R., Lopez A.R., Derynck R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells. involvement of type I receptors J. Cell Biol. 127:1994;2021-2036.
65. Montross W.T., Ji H., McCrea P.D. A beta-catenin/engrailed chimera selectively suppresses Wnt signaling. J. Cell Sci. 113:2000;1759-1770.
66. Morali O.G., Delmas V., Moore R., Jeanney C., Thiery J.P., Larue L. IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene. 20:2001;4942-4950.
67. Morin P.J. beta-catenin signaling and cancer. Bioessays. 21:1999;1021-1030.
68. Mouraviev V., Li L., Tahir S.A., Yang G., Timme T.M., Goltsov A., Ren C., Satoh T., Wheeler T.M., Ittmann M.M.et al. The role of caveolin-1 in androgen insensitive prostate cancer. J. Urol. 168:2002;1589-1596.
69. Muller T., Bain G., Wang X., Papkoff J. Regulation of epithelial cell migration and tumor formation by beta-catenin signaling. Exp. Cell Res. 280:2002;119-133.
70. Nagafuchi A. Molecular architecture of adherens junctions. Curr. Opin. Cell Biol. 13:2001;600-603.
71. Nasu Y., Timme T.L., Yang G., Bangma C.H., Li L., Ren C., Park S.H., DeLeon M., Wang J., Thompson T.C. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells. Nat. Med. 4:1998;1062-1064.
72. Okamoto T., Schlegel A., Scherer P.E., Lisanti M.P. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273:1998;5419-5422.
73. Okamoto Y., Ninomiya H., Miwa S., Masaki T. Cholesterol oxidation switches the internalization pathway of endothelin receptor type A from caveolae to clathrin-coated pits in Chinese hamster ovary cells. J. Biol. Chem. 275:2000;6439-6446.
74. Orford K., Orford C.C., Byers S.W. Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. J. Cell Biol. 146:1999;855-868.
75. Palacios F., D'Souza-Schorey C. Modulation of Rac1 and ARF6 activation during epithelial cell scattering. J. Biol. Chem. 278:2003;17395-17400.
76. Palacios F., Price L., Schweitzer J., Collard J.G., D'Souza-Schorey C. An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration. EMBO J. 20:2001;4973-4986.
77. Palacios F., Schweitzer J.K., Boshans R.L., D'Souza-Schorey C. ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly. Nat. Cell Biol. 4:2002;929-936.
78. Palmer H.G., Gonzalez-Sancho J.M., Espada J., Berciano M.T., Puig I., Baulida J., Quintanilla M., Cano A., de Herreros A.G., Lafarga M., Munoz A. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J. Cell Biol. 154:2001;369-387.
79. Papkoff J. Regulation of complexed and free catenin pools by distinct mechanisms. Differential effects of Wnt-1 and V-Src. J. Biol. Chem. 272:1997;4536-4543.
80. Park D.S., Razani B., Lasorella A., Schreiber-Agus N., Pestell R.G., Iavarone A., Lisanti M.P. Evidence that Myc isoforms transcriptionally repress caveolin-1 gene expression via an INR-dependent mechanism. Biochemistry. 40:2001;3354-3362.
81. Paterson A.D., Parton R.G., Ferguson C., Stow J.L., Yap A.S. Characterization of E-cadherin endocytosis in isolated MCF-7 and cho cells. the initial fate of unbound E-cadherin J. Biol. Chem. 278:2003;21050-21057.
82. Peifer M., Polakis P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science. 287:2000;1606-1609.
83. Peinado H., Quintanilla M., Cano A. Transforming Growth Factor {beta}-1 induces Snail transcription factor in epithelial cell lines. mechanisms for epithelial mesenchymal transitions J. Biol. Chem. 278:2003;21113-21123.
84. Pelkmans L., Kartenbeck J., Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 3:2001;473-483.
85. Perl A.K., Wilgenbus P., Dahl U., Semb H., Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 392:1998;190-193.
86. Pol A., Calvo M., Lu A., Enrich C. EGF triggers caveolin redistribution from the plasma membrane to the early/sorting endocytic compartment of hepatocytes. Cell. Signal. 12:2000;537-540.
87. Polo S., Sigismund S., Faretta M., Guidi M., Capua M.R., Bossi G., Chen H., De Camilli P., Di Fiore P.P. A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins. Nature. 416:2002;451-455.
88. Poser I., Dominguez D., de Herreros A.G., Varnai A., Buettner R., Bosserhoff A.K. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. J. Biol. Chem. 276:2001;24661-24666.
89. Price J.T., Wilson H.M., Haites N.E. Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. Eur. J. Cancer. 32A:1996;1977-1982.
90. Racine C., Belanger M., Hirabayashi H., Boucher M., Chakir J., Couet J. Reduction of caveolin 1 gene expression in lung carcinoma cell lines. Biochem. Biophys. Res. Commun. 255:1999;580-586.
91. Razani B., Engelman J.A., Wang X.B., Schubert W., Zhang X.L., Marks C.B., Macaluso F., Russell R.G., Li M., Pestell R.G.et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276:2001;38121-38138. a.
92. Razani B., Schlegel A., Liu J., Lisanti M.P. Caveolin-1, a putative tumour suppressor gene. Biochem. Soc. Trans. 29:2001;494-499. b.
93. Razandi M., Alton G., Pedram A., Ghonshani S., Webb P., Levin E.R. Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane. Mol. Cell. Biol. 23:2003;1633-1646.
94. Rimm D.L., Koslov E.R., Kebriaei P., Cianci C.D., Morrow J.S. Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc. Natl. Acad. Sci. USA. 92:1995;8813-8817.
95. Ros-Baro A., Lopez-Iglesias C., Peiro S., Bellido D., Palacin M., Zorzano A., Camps M. Lipid rafts are required for GLUT4 internalization in adipose cells. Proc. Natl. Acad. Sci. USA. 98:2001;12050-12055.
96. Rosen E.M., Goldberg I.D. Protein factors which regulate cell motility. In Vitro Cell. Dev. Biol. 25:1989;1079-1087.
97. Rubinfeld B., Albert I., Porfiri E., Fiol C., Munemitsu S., Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science. 272:1996;1023-1026.
98. Salahshor S., Hou H., Diep C.B., Loukola A., Zhang H., Liu T., Chen J., Iselius L., Rubio C., Lothe R.A.et al. A germline E-cadherin mutation in a family with gastric and colon cancer. Int. J. Mol. Med. 8:2001;439-443.
99. Salomon D.S., Brandt R., Ciardiello F., Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol. 19:1995;183-232.
100. Savagner P., Yamada K.M., Thiery J.P. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J. Cell Biol. 137:1997;1403-1419.
101. Scherer P.E., Tang Z., Chun M., Sargiacomo M., Lodish H.F., Lisanti M.P. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J. Biol. Chem. 270:1995;16395-16401.
102. Schlegel A., Wang C., Katzenellenbogen B.S., Pestell R.G., Lisanti M.P. Caveolin-1 potentiates estrogen receptor alpha (ERalpha) signaling. caveolin-1 drives ligand-independent nuclear translocation and activation of ERalpha. J. Biol. Chem. 274:1999;33551-33556.
103. Shibata T., Kawano T., Nagayasu H., Okumura K., Arisue M., Hamada J., Takeichi N., Hosokawa M. Enhancing effects of epidermal growth factor on human squamous cell carcinoma motility and matrix degradation but not growth. Tumour Biol. 17:1996;168-175.
104. Shih S.C., Katzmann D.J., Schnell J.D., Sutanto M., Emr S.D., Hicke L. Epsins and Vps27p/Hrs contain ubiquitin-binding domains that function in receptor endocytosis. Nat. Cell Biol. 4:2002;389-393.
105. Shin J.S., Abraham S.N. Cell biology. Caveolae - not just craters in the cellular landscape. Science. 293:2001;1447-1448.
106. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA. 96:1999;5522-5527.
107. Singh A.B., Harris R.C. EGF Receptor activation differentially regulates claudin expression and enhances trans-epithelial resistance in MDCK cells. J. Biol. Chem. in press:2003;. Published online October 30, 2003. 10.1074/jbc.M308682200.
108. Smart E.J., Ying Y., Donzell W.C., Anderson R.G. A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J. Biol. Chem. 271:1996;29427-29435.
109. Stockinger A., Eger A., Wolf J., Beug H., Foisner R. E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. J. Cell Biol. 154:2001;1185-1196.
110. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:1999;422-426.
111. Thomsen P., Roepstorff K., Stahlhut M., van Deurs B. Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking. Mol. Biol. Cell. 13:2002;238-250.
112. Tillotson J.K., Rose D.P. Endogenous secretion of epidermal growth factor peptides stimulates growth of DU145 prostate cancer cells. Cancer Lett. 60:1991;109-112.
113. Torgersen M.L., Skretting G., van Deurs B., Sandvig K. Internalization of cholera toxin by different endocytic mechanisms. J. Cell Sci. 114:2001;3737-3747.
114. Tsarfaty I., Rong S., Resau J.H., Rulong S., da Silva P.P., Vande Woude G.F. The Met proto-oncogene mesenchymal to epithelial cell conversion. Science. 263:1994;98-101.
115. Valles A.M., Boyer B., Badet J., Tucker G.C., Barritault D., Thiery J.P. Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder carcinoma cell line. Proc. Natl. Acad. Sci. USA. 87:1990;1124-1128.
116. Vasioukhin V., Fuchs E. Actin dynamics and cell-cell adhesion in epithelia. Curr. Opin. Cell Biol. 13:2001;76-84.
117. Vasioukhin V., Bauer C., Degenstein L., Wise B., Fuchs E. Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin. Cell. 104:2001;605-617.
118. Vleminckx K., Vakaet L. Jr., Mareel M., Fiers W., van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 66:1991;107-119.
119. Voldborg B.R., Damstrup L., Spang-Thomsen M., Poulsen H.S. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann. Oncol. 8:1997;1197-1206.
120. Weidner K.M., Behrens J., Vandekerckhove J., Birchmeier W. Scatter factor. molecular characteristics and effect on the invasiveness of epithelial cells J. Cell Biol. 111:1990;2097-2108.
121. Weston C.R., Davis R.J. Signal transduction. signaling specificity - a complex affair Science. 292:2001;2439-2440.
122. Wiechen K., Sers C., Agoulnik A., Arlt K., Dietel M., Schlag P.M., Schneider U. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am. J. Pathol. 158:2001;833-839.
123. Wodarz A., Nusse R. Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14:1998;59-88.
124. Yost C., Torres M., Miller J.R., Huang E., Kimelman D., Moon R.T. The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev. 10:1996;1443-1454.